China SXT Pharmaceuticals... (SXTC)
0.43
-0.03 (-6.32%)
At close: Jan 28, 2025, 2:57 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 12.07M | 17.37M | 15.52M | 13.33M | 7.29M | 9.13M | 560.25K | 65.57K | 11.44K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | -441.21K | -13.50K | -6.17K | n/a | n/a |
| Other Long-Term Assets | 8.31M | 8.74M | 9.46M | 9.16M | 441.21K | 13.50K | 6.17K | n/a | n/a |
| Receivables | 1.35M | 1.34M | 4.91M | 7.77M | 10.65M | 4.93M | 3.91M | 3.82M | 4.06M |
| Inventory | 809.76K | 531.25K | 1.02M | 859.70K | 892.77K | 1.01M | 1.27M | 890.79K | 1.72M |
| Other Current Assets | 6.84K | 230.64K | 995.83K | 1.27M | 809.10K | 516.89K | 361.93K | 128.70K | -59.38K |
| Total Current Assets | 14.23M | 19.52M | 22.45M | 23.23M | 19.64M | 15.59M | 6.10M | 4.91M | 5.83M |
| Property-Plant & Equipment | 564.69K | 1.27M | 1.59M | 1.79M | 1.90M | 1.81M | 1.49M | 485.29K | 430.08K |
| Goodwill & Intangibles | 19.10K | 27.87K | 38.76K | 45.80K | 50.05K | 61.10K | 60.67K | 41.00K | 41.40K |
| Total Long-Term Assets | 8.89M | 10.03M | 11.09M | 11.31M | 2.07M | 1.88M | 1.56M | 526.30K | 471.48K |
| Total Assets | 23.13M | 29.55M | 33.55M | 34.55M | 21.70M | 17.47M | 7.66M | 5.43M | 6.30M |
| Account Payables | 1.28M | 1.38M | 1.48M | 1.46M | 1.94M | 1.69M | 2.41M | 1.26M | 2.89M |
| Deferred Revenue | 187.66K | 165.53K | 77.37K | 257.45K | 298.04K | 57.55K | 292.95K | 585.97K | 543.94K |
| Short-Term Debt | 2.35M | 3.39M | 2.05M | 37.12K | 6.69M | 233.34K | 385.12K | 302.17K | 479.23K |
| Other Current Liabilities | 4.03M | 8.46M | 12.35M | 15.67M | 2.35M | 3.25M | 709.17K | 1.72M | 1.64M |
| Total Current Liabilities | 8.90M | 14.50M | 17.12M | 18.58M | 12.26M | 6.32M | 4.37M | 3.58M | 5.55M |
| Long-Term Debt | 294.67K | 365.82K | n/a | 6.29K | 36.51K | 41.71K | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 294.67K | 365.82K | 3.61M | 6.29K | 36.51K | 41.71K | n/a | n/a | n/a |
| Total Liabilities | 9.20M | 14.86M | 17.12M | 18.59M | 12.30M | 6.36M | 4.37M | 3.58M | 5.55M |
| Total Debt | 2.65M | 3.76M | 2.05M | 43.41K | 6.72M | 261.15K | 385.12K | 302.17K | 479.23K |
| Common Stock | 4.35M | 913.78K | 162.47K | 62.06K | 34.67K | 22.71K | 20.00K | 20.00K | 20.00K |
| Retained Earnings | -24.71M | -21.61M | -15.69M | -9.95M | -7.20M | 3.08M | 1.54M | 357.06K | -828.08K |
| Comprehensive Income | -1.03M | -197.57K | 956.14K | 527.79K | -590.66K | 50.40K | 257.37K | 11.82K | 87.09K |
| Shareholders Equity | 13.93M | 14.69M | 16.42M | 15.96M | 9.40M | 11.11M | 3.29M | 1.85M | 742.77K |
| Total Investments | -6.84K | n/a | n/a | n/a | -441.21K | -13.50K | -6.17K | n/a | n/a |